Board Advisor

Terry has over 20 years’ experience in commercialising IP and Life Sciences and Health-related technologies and research, through the creation of new companies, licensing relationships and partnerships. 

He holds a PhD in immunology and gene silencing and held a postdoctoral research position within the UK's first stem cell spin-out company, Cerestem Ltd. He currently serves as the Commercialisation Director, Deputy Head of Life Sciences for Cambridge Enterprise, the commercialisation arm of the University of Cambridge.